期刊文献+

肿瘤患者红细胞输注无效的影响因素分析 被引量:15

Influence Factors of Invalid Red Blood Cell Transfusion in Tumor Patients
原文传递
导出
摘要 [目的]分析肿瘤患者红细胞输注无效的相关因素,为临床肿瘤患者科学、有效的输血提供依据。[方法]回顾性分析2014年1月至2016年4月衢州市柯城区人民医院485例肿瘤患者红细胞输注无效与相关因素之间的关系,分析输血不良反应发生率与输血效果的关联性。用Logistic回归分析可能影响肿瘤患者红细胞输注无效的因素。[结果]肿瘤患者红细胞输注无效比例为21.65%(105/485)。单因素分析显示肿瘤患者红细胞输注无效与既往输血次数、既往输血量及妊娠次数密切相关;迟发型溶血反应的发生率与肿瘤患者红细胞输注效果密切相关。Logistic回归分析显示多次输血(OR=8.48,P=0.00)是肿瘤患者红细胞输注无效的独立危险因素。[结论]有多次输血史的肿瘤患者发生红细胞输注无效的风险较高。针对有反复输血史的肿瘤患者,应制定独立、安全、有效的个体化输血策略。 [Objective] To analyze the related factors associated with invalid red blood cell transfusion in tumor patients, and to provide evidence for scientific and effective clinical blood transfusion. [Methods] The retrospective analysis of the relationship between invalid red blood cell transfusion and related factors in 485 tumor patients in Quzhou Kecheng People's Hospital from January 2014 to April 2016 was enrolled. The relationship between the incidence of tansfusion adverse reactions and the effectiveness of blood transfusion were analyzed. The potential factors associated with invalid red blood cell transfusion in tumor patients were evaluated by Logistic regression. [Results] The proportion of invalid red blood cell transfusion in tumor patients was 21.65%(105/485). The single factor analysis showed that the number of always blood transfusion , the volume of always blood transfusion, and the number of pregnancy were closely related to invalid red blood cell transfusion in tumor patients. The incidence rate of late onset hemolytic reaction was closely related to the effectiveness of red blood cell transfusion in tumor patients. Logistic regression analysis showed that multiple transfusions(OR=8.48,P=0.00) were independent factors for invalid red blood cell transfusion in tumor patients . [Conclusion] The tumor patients with history of multiple transfusions are at high risk for invalid blood transfusion. For the tumor patients with repeated blood transfusion history,the independent,safe and effective individualized transfusion strategy should be formulated.
作者 汪淑芬 王晓稼 吴启旺 李兰福 吴先华 WANG Shu-fen WANG Xiao-jia WU Qi-wang et al(Quzhou Kecheng People's Hospital,Quzhou 324000,China Zhejiang Cancer Hospital, Hangzhou 310022, China)
出处 《肿瘤学杂志》 CAS 2017年第5期424-427,共4页 Journal of Chinese Oncology
关键词 肿瘤患者 红细胞输注无效 影响因素 肿瘤相关性贫血 tumor patients invalid red blood cell transfusion influence factor cancer-related
  • 相关文献

参考文献6

二级参考文献47

  • 1傅勤,林建华.正常妊娠中、晚期与分娩期血流动力学变化的研究[J].上海医学,2005,28(9):731-733. 被引量:6
  • 2夏爱军,穆士杰,张献清,孙文利,陈晨.健康献血者红细胞血型不规则抗体筛选在临床输血中的意义[J].中国输血杂志,2005,18(6):493-494. 被引量:30
  • 3吕运来,贠中桥,兰炯采,孙先玲,杨波,张艳艳.红细胞无效输注回顾性初探[J].中国输血杂志,2007,20(3):220-221. 被引量:70
  • 4Carson JL, Grossman BJ, Kleinman S, et al. Red Blood Cell Transfu- sion:A Clinical Practice Guideline From the AABB [ J ]. Ann Intern Med,2012,3(4) :423.
  • 5Henrichs KF, Howk N, Masel DS, et al. Providing ABO-identical plate- lets and cryoprecipitate to ( almost ) all patients : approach, logistics, and associated decreases in transfusion reaction and redblood cell allo- immunization incidence [ J 1. Transfusion,2012,52 ( 3 ) :635.
  • 6Weiskopf RB, Feiner J, Toy P, et al. Fresh and stored red blood cell transfusion equivalently induce subclinicalpulmonary gas exchange deficit in normal humans [ J ]. Anesth Analg,2012, 114 ( 3 ) :511.
  • 7兰炯采,负中桥,陈静娴.输血免疫学实验技术.北京:人民卫生出版社,2011:22-82.
  • 8夏荣,兰炯采.重视红细胞输注无效,提高临床输血效果[J].中国输血杂志,2008,21(1):5-5. 被引量:58
  • 9兰炯采,吕运来,负中桥.红细胞无效输注的相关实验.输血免疫学实验技术.北京:人民卫生出版社,2011:187-188.
  • 10AABB. Technical manual, 16th ed, Bethesda : AABB ,2008:479.

共引文献70

同被引文献120

引证文献15

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部